본문 바로가기
KERD
논문KCI 등재

Synapses in neurodegenerative diseases

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류화학

초록

Synapse is the basic structural and functional component for neural communication in the brain. The presynaptic terminal is the structural and functionally essential area that initiates communication and maintains the continuous functional neural information flow. It contains synaptic vesicles (SV) filled with neurotransmitters, an active zone for release, and numerous proteins for SV fusion and retrieval. The structural and functional synaptic plasticity is a representative characteristic; however, it is highly vulnerable to various pathological conditions. In fact, synaptic alteration is thought to be central to neural disease processes. In particular, the alteration of the structural and functional phenotype of the presynaptic terminal is a highly significant evidence for neural diseases. In this review, we specifically describe structural and functional alteration of nerve terminals in several neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD).

Abstract

Synapse is the basic structural and functional component for neural communication in the brain. The presynaptic terminal is the structural and functionally essential area that initiates communication and maintains the continuous functional neural information flow. It contains synaptic vesicles (SV) filled with neurotransmitters, an active zone for release, and numerous proteins for SV fusion and retrieval. The structural and functional synaptic plasticity is a representative characteristic; however, it is highly vulnerable to various pathological conditions. In fact, synaptic alteration is thought to be central to neural disease processes. In particular, the alteration of the structural and functional phenotype of the presynaptic terminal is a highly significant evidence for neural diseases. In this review, we specifically describe structural and functional alteration of nerve terminals in several neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD).

참고문헌 (96)

  1. Ikin AF, "Alzheimer amyloid protein precursor is localized in nerve terminal preparations to Rab5-containing vesicular organelles distinct from those implicated in the synaptic vesicle pathway", J Biol Chem, 271, pp.31783~31786 (1996)
  2. Groemer TW, "Amyloid precursor protein is trafficked and secreted via synaptic vesicles", PLoS One, 66, pp.e18754~ (2011)
  3. Priller C, "Synapse formation and function is modulated by the amyloid precursor protein", J Neurosci, 26, pp.7212~7221 (2006)
  4. Lassek M, "APP Is a Context-Sensitive Regulator of the Hippocampal Presynaptic Active Zone", PLoS Comput Biol, 12, pp.e1004832~ (2016)
  5. Jang BG, "Beta-amyloid oligomers induce early loss of presynaptic proteins in primary neurons by caspase-dependent and proteasomedependent mechanisms", Neuroreport, 25, pp.1281~1288 (2014)
  6. Abramov E, "Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses", Nat Neurosci, 12, pp.1567~1576 (2009)
  7. Fogel H, "APP homodimers transduce an amyloid-beta-mediated increase in release probability at excitatory synapses", Cell Rep, 7, pp.1560~1576 (2014)
  8. Romani A, "Computational modeling of the effects of amyloid-beta on release probability at hippocampal synapses", Front Comput Neurosci, 7, pp.1~ (2013)
  9. Russell CL, "Amyloid-beta acts as a regulator of neurotransmitter release disrupting the interaction between synaptophysin and VAMP2", PLoS One, 7, pp.e43201~ (2012)
  10. Cirrito JR, "Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo", Neuron, 48, pp.913~922 (2005)
  11. Cirrito JR, "Endocytosis is required for synaptic activity-dependent release of amyloidbeta in vivo", Neuron, 58, pp.42~51 (2008)
  12. Munro KM, "Functions of the Alzheimer's Disease Protease BACE1 at the Synapse in the Central Nervous System", J Mol Neurosci, 60, pp.305~315 (2016)
  13. Lundgren JL, "ADAM10 and BACE1 are localized to synaptic vesicles", J Neurochem, 135, pp.606~615 (2015)
  14. Del Prete D, "APP is cleaved by Bace1 in pre-synaptic vesicles and establishes a pre-synaptic interactome, via its intracellular domain, with molecular complexes that regulate presynaptic vesicles functions", PLoS One, 9, pp.e108576~ (2014)
  15. Petrus E, "BACE1 is necessary for experience-dependent homeostatic synaptic plasticity in visual cortex", Neural Plast, 2014, pp.128631~ (2014)
  16. Frykman S, "Synaptic and endosomal localization of active gamma-secretase in rat brain", PLoS One, 5, pp.e8948~ (2010)
  17. Zhang C, "Presenilins are essential for regulating neurotransmitter release", Nature, 460, pp.632~636 (2009)
  18. Pratt KG, "Presenilin 1 regulates homeostatic synaptic scaling through Akt signaling", Nat Neurosci, 14, pp.1112~1114 (2011)
  19. Spires-Jones TL, "The intersection of amyloid beta and tau at synapses in Alzheimer's disease", Neuron, 82, pp.756~771 (2014)
  20. Voelzmann A, "Tau and spectraplakins promote synapse formation and maintenance through Jun kinase and neuronal trafficking", Elife, 5 (2016)
  21. Jadhav S, "Truncated tau deregulates synaptic markers in rat model for human tauopathy", Front Cell Neurosci, 9, pp.24~ (2015)
  22. Kopeikina KJ, "Synaptic alterations in the rTg4510 mouse model of tauopathy", J Comp Neurol, 521, pp.1334~1353 (2013)
  23. Kopeikina KJ, "Tau causes synapse loss without disrupting calcium homeostasis in the rTg4510 model of tauopathy", PLoS One, 8, pp.e80834~ (2013)
  24. Levi O, "ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory", Neurobiol Dis, 13, pp.273~282 (2003)
  25. Zhu Y, "APOE genotype alters glial activation and loss of synaptic markers in mice", Glia, 60, pp.559~569 (2012)
  26. Cambon K, "Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice", Neuroscience, 97, pp.685~692 (2000)
  27. Dumanis SB, "APOE genotype affects the presynaptic compartment of glutamatergic nerve terminals", J Neurochem, 124, pp.4~14 (2013)
  28. Bal M, "Reelin mobilizes a VAMP7-dependent synaptic vesicle pool and selectively augments spontaneous neurotransmission", Neuron, 80, pp.934~946 (2013)
  29. Koffie RM, "Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-beta", Brain, 135, pp.2155~2168 (2012)
  30. Picconi B, "Synaptic dysfunction in Parkinson's disease", Adv Exp Med Biol, 970, pp.553~572 (2012)
  31. Belluzzi E, "Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2", Biochem Soc Trans, 40, pp.1111~1116 (2012)
  32. Stefanis L, "alpha-Synuclein in Parkinson's disease", Cold Spring Harb Perspect Med, 2, pp.a009399~ (2012)
  33. Goedert M, "Alpha-synuclein and neurodegenerative diseases", Nat Rev Neurosci, 2, pp.492~501 (2001)
  34. Norris EH, "Alphasynuclein : normal function and role in neurodegenerative diseases", Curr Top Dev Biol, 60, pp.17~54 (2004)
  35. Rizo J, "The membrane fusion enigma: SNAREs, Sec1", Munc18 proteins, and their accomplices--guilty as charged?, 2012, pp.28, 279~308
  36. Tanji K, "Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice", Acta Neuropathol, 120, pp.145~154 (2010)
  37. Spinelli KJ, "Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease", J Neurosci, 34, pp.2037~2050 (2014)
  38. Lundblad M, "Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons", Proc Natl Acad Sci U S A, 109, pp.3213~3219 (2012)
  39. Xu J, "alpha-Synuclein Mutation Inhibits Endocytosis at Mammalian Central Nerve Terminals", J Neurosci, 36, pp.4408~4414 (2016)
  40. Nemani VM, "Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis", Neuron, 65, pp.66~79 (2010)
  41. Scott D, "alpha-Synuclein inhibits intersynaptic vesicle mobility and maintains recyclingpool homeostasis", J Neurosci, 32, pp.10129~10135 (2012)
  42. Mills RD, "Prediction of the repeat domain structures and impact of parkinsonism-associated variations on structure and function of all functional domains of leucine-rich repeat kinase 2 (LRRK2)", Hum Mutat, 35, pp.395~412 (2014)
  43. Martin I, "LRRK2 pathobiology in Parkinson's disease", J Neurochem, 131, pp.554~565 (2014)
  44. Lee S, "LRRK2 kinase regulates synaptic morphology through distinct substrates at the presynaptic and postsynaptic compartments of the Drosophila neuromuscular junction", J Neurosci, 30, pp.16959~16969 (2010)
  45. Matta S, "LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis", Neuron, 75, pp.1008~1021 (2012)
  46. Arranz AM, "LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism", J Cell Sci, 128, pp.541~552 (2015)
  47. Belluzzi E, "LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate", Mol Neurodegener, 11, pp.1~ (2016)
  48. Li X, "Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S", J Neurosci, 30, pp.1788~1797 (2010)
  49. Beccano-Kelly DA, "Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice", Front Cell Neurosci, 8, pp.301~ (2014)
  50. Beccano-Kelly DA, "LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory", Hum Mol Genet, 24, pp.1336~1349 (2015)
  51. Leroy E, "Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease", Hum Genet, 103, pp.424~427 (1998)
  52. Lucking CB, "Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism", Lancet, 352, pp.1355~1356 (1998), The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Group
  53. Kitada T, "Impaired dopamine release and synaptic plasticity in the striatum of parkin-", - mice, 2009, pp.110, 613~621
  54. Helton TD, "Pruning and loss of excitatory synapses by the parkin ubiquitin ligase", Proc Natl Acad Sci U S A, 105, pp.19492~19497 (2008)
  55. Cortese GP, "Parkin Deficiency Reduces Hippocampal Glutamatergic Neurotransmission by Impairing AMPA Receptor Endocytosis", J Neurosci, 36, pp.12243~12258 (2016)
  56. Khandelwal PJ, "Parkinson-related parkin reduces alpha-Synuclein phosphorylation in a gene transfer model", Mol Neurodegener, 5, pp.47~ (2010)
  57. Zhang Y, "Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1", Proc Natl Acad Sci U S A, 97, pp.13354~13359 (2000)
  58. Chung KK, "Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease", Nat Med, 7, pp.1144~1150 (2001)
  59. Valente EM, "Hereditary early-onset Parkinson's disease caused by mutations in PINK1", Science, 304, pp.1158~1160 (2004)
  60. Beilina A, "Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability", Proc Natl Acad Sci U S A, 102, pp.5703~5708 (2005)
  61. Plun-Favreau H, "The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1", Nat Cell Biol, 9, pp.1243~1252 (2007)
  62. Morais VA, "Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function", EMBO Mol Med, 1, pp.99~111 (2009)
  63. Xi Y, "Impaired dopaminergic neuron development and locomotor function in zebrafish with loss of pink1 function", Eur J Neurosci, 31, pp.623~633 (2010)
  64. Kitada T, "Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice", Proc Natl Acad Sci U S A, 104, pp.11441~11446 (2007)
  65. Junn E, "Mitochondrial localization of DJ-1 leads to enhanced neuroprotection", J Neurosci Res, 87, pp.123~129 (2009)
  66. Bonifati V, "Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism", Science, 299, pp.256~259 (2003)
  67. Usami Y, "DJ-1 associates with synaptic membranes", Neurobiol Dis, 43, pp.651~662 (2011)
  68. Goldberg MS, "Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1", Neuron, 45, pp.489~496 (2005)
  69. Slepnev VI, "Accessory factors in clathrin-dependent synaptic vesicle endocytosis", Nat Rev Neurosci, 1, pp.161~172 (2000)
  70. McPherson PS, "A presynaptic inositol-5-phosphatase", Nature, 379, pp.353~357 (1996)
  71. Mani M, "The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals", Neuron, 56, pp.1004~1018 (2007)
  72. Krebs CE, "The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures", Hum Mutat, 34, pp.1200~1207 (2013)
  73. Quadri M, "Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism", Hum Mutat, 34, pp.1208~1215 (2013)
  74. Hardies K, "Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline", Brain, 139, pp.2420~2430 (2016)
  75. Cao M, "Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic Axons", Neuron, 93, pp.882~896 (2017)
  76. Cao M, "Upregulation of Parkin in endophilin mutant mice", J Neurosci, 34, pp.16544~16549 (2014)
  77. Schuske KR, "Endophilin is required for synaptic vesicle endocytosis by localizing synaptojanin", Neuron, 40, pp.749~762 (2003)
  78. Soukup SF, "A LRRK2-Dependent EndophilinA Phosphoswitch Is Critical for Macroautophagy at Presynaptic Terminals", Neuron, 92, pp.829~844 (2016)
  79. Felbecker A, "Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic?", J Neurol Neurosurg Psychiatry, 81, pp.572~577 (2010)
  80. Robberecht W, "D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis", Neurology, 47, pp.1336~1339 (1996)
  81. Andersen PM, "Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene", Curr Neurol Neurosci Rep, 6, pp.37~46 (2006)
  82. 이도연, "Modulation of SOD1 Subcellular Localization by Transfection with Wild- or Mutant-type SOD1 in Primary Neuron and Astrocyte Cultures from ALS Mice", Experimental Neurobiology, 24(3), pp.226~234 (2015), 한국뇌신경과학회
  83. Jae Ryul Bae, "Impairment of SOD1-G93A motility is linked to mitochondrial movement in axons of hippocampal neurons", Archives of Pharmacal Research, 39(8), pp.1144~1150 (2016), 대한약학회
  84. Tallon C, "Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice", Neuroscience, 312, pp.179~189 (2016)
  85. Zang DW, "Loss of synaptophysin-positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS", J Neurosci Res, 79, pp.694~699 (2005)
  86. Gregory RI, "The Microprocessor complex mediates the genesis of microRNAs", Nature, 432, pp.235~240 (2004)
  87. Xu ZS, "Does a loss of TDP-43 function cause neurodegeneration?", Mol Neurodegener, 7, pp.27~ (2012)
  88. Medina DX, "Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice", Neurobiol Aging, 35, pp.79~87 (2014)
  89. Handley EE, "Synapse Dysfunction of Layer V Pyramidal Neurons Precedes Neurodegeneration in a Mouse Model of TDP-43 Proteinopathies", Cereb Cortex, pp.1~18 (2016)
  90. Nolan M, "Pathogenesis of FUS-associated ALS and FTD: insights from rodent models", Acta Neuropathol Commun, 4, pp.99~ (2016)
  91. Da Cruz S, "Understanding the role of TDP-43 and FUS", TLS in ALS and beyond, 2011, pp.21, 904~919
  92. Lagier-Tourenne C, "Rethinking ALS: the FUS about TDP-43", Cell, 136, pp.1001~1004 (2009)
  93. Machamer JB, "The ALS gene FUS regulates synaptic transmission at the Drosophila neuromuscular junction", Hum Mol Genet, 23, pp.3810~3822 (2014)
  94. Romero E, "Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm", Neuron, 57, pp.27~40 (2008)
  95. Deak F, "Rabphilin regulates SNARE-dependent re-priming of synaptic vesicles for fusion", EMBO J, 25, pp.2856~2866 (2006)
  96. Parker JA, "Huntingtininteracting protein 1 influences worm and mouse presynaptic function and protects Caenorhabditis elegans neurons against mutant polyglutamine toxicity", J Neurosci, 27, pp.11056~11064 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (7건)